Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for 002626.SZ and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for 002626.SZ and 80,000+ other tickers.
See exactly how 002626.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 002626.SZ and 80,000+ other tickers.
Xiamen Kingdomway Group Company operates as a global producer and distributor of a variety of nutritional and health-focused goods. The company's offerings encompass a selection of fundamental raw ingredients, notably coenzyme Q10, Vitamin A, Vitamin D3, DHA derived from microalgae, and plant-based ARA. Furthermore, it manufactures ready-to-use dietary supplements and specialized sports nutrition products. Originally established in 1997, the firm was previously recognized as Xiamen Jindawei Vitamin Co., Ltd., and maintains its principal offices in Xiamen, China.
No recent news available.